Diagnostic evaluation of clinically normal subjects with chronic hyperCKemia

Neurology

Volumn 66, Issue 10, 2006, Pages 1585-1587

  Fernandez, C ^a   De Paula, A Maues ^a   Figarella Branger, D ^a   Krahn, M ^a   Giorgi, R ^b   Chabrol, B ^a   Monfort, M F ^a   Pouget, J ^a   Pellissier, J F ^a,c  

^a TIMONE HOSPITAL   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c Service d'anatomie pathologique et de neuropathologie HÔpital de la Timone AP HM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; BIOLOGICAL MARKER; CREATINE KINASE MM; DYSTROPHIN;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; ENZYME ACTIVITY; ENZYME DEFECT; FEMALE; GLYCOGEN STORAGE DISEASE; HISTOCHEMISTRY; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPER CREATINE KINASEMIA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MUSCLE BIOPSY; MUSCULAR DYSTROPHY; MYOSITIS; PRIORITY JOURNAL; WESTERN BLOTTING; BIOPSY; BLOOD; COHORT ANALYSIS; ENZYMOLOGY; FATIGUE; GLYCOGEN STORAGE DISEASE TYPE 2; GLYCOGEN STORAGE DISEASE TYPE 5; MIDDLE AGED; MUSCLE CRAMP; NEUROMUSCULAR DISEASE; PATHOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SKELETAL MUSCLE;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CREATINE KINASE, MM FORM; DYSTROPHIN; FATIGUE; FEMALE; GLYCOGEN STORAGE DISEASE TYPE II; GLYCOGEN STORAGE DISEASE TYPE V; HUMANS; MALE; MIDDLE AGED; MUSCLE CRAMP; MUSCLE, SKELETAL; NEUROMUSCULAR DISEASES; RETROSPECTIVE STUDIES;

EID: 33745424580     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000216144.69630.6e     Document Type: Article

References (10)

1. Reijneveld JC, Notermans NC, Linssen WH, Wokke JH. Benign prognosis in idiopathic hyper-CK-emia. Muscle Nerve 2000;23:575-579.
2. Simmons Z, Peterlin BL, Boyer PJ, Towfighi J. Muscle biopsy in the evaluation of patients with modestly elevated creatine kinase levels. Muscle Nerve 2003;27:242-244.
3. Prelle A, Tancredi L, Sciacco M, et al. Retrospective study of a large population of patients with asymptomatic or minimally symptomatic raised serum creatine kinase levels. J Neurol 2002;249:305-311.
4. Joy JL, Oh SJ. Asymptomatic hyper-CK-emia: an electrophysiologic and histopathologic study. Muscle Nerve 1989;12:206-209.
5. Reijneveld JC, Notermans NC, Linssen WH, Bar PR, Wokke JH. HyperCK-aemia revisited. Neuromuscul Disord 2001;11:163-164.
6. Morrone A, Zammarchi E, Scacheri PC, et al. Asymptomatic dystrophinopathy. Am J Med Genet 1997;69:261-267.
7. De Paula F, Vieira N, Starling A, et al. Asymptomatic carriers for homozygous novel mutations in the FKRP gene: the other end of the spectrum. Eur J Hum Genet 2003;11:923-930.
8. Capasso M, Lupo S, Di Muzio A, Uncini A, Servidei S. Immunohistochemical study of caveolin-3 in idiopathic hyperCKaemia. J Neurol Neurosurg Psychiatry 2003;74:547-548.
9. Gherardi RK, Coquet M, Cherin P, et al. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. Brain 2001;124:1821-1831.
10. Weglinski MR, Wedel DJ, Engel AG. Malignant hyperthermia testing in patients with persistently increased serum creatine kinase levels. Anesth Analg 1997;84:1038-1041.